Enzyme Replacement Therapy Market By Enzyme (Pegademase, Velaglucerase Alfa, Agalsidase Beta, Imiglucerase, Taliglucerase, Laronidase, Alglucosidase Alfa, And Other Enzymes), By Therapeutic Condition (Pompe’s Disease, Gaucher’s Disease, MPS, Fabry’s Disease, SCID, and others), By Route Of Administration (Oral And Parenteral), By End-User (hospitals, infusion centers, and others), and By Region – Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032

Global enzyme replacement therapy market is expected to generate revenue of around USD 19.78 Billion by 2032, growing at a CAGR of around 6.68% between 2024 and 2032.

全球酶替代疗法市场预计到2032年将实现约197.8亿美元的收益，在2024年至2032年期间，其复合年增长率约为6.68%。